论文信息 - Multicenter phase II study of infusional 5-fluorouracil (5-FU), leucovorin, and oxaliplatin, plus biweekly cetuximab as first-line treatment in patients with metastatic colorectal cancer (CELINE trial) - 字舞流文

Multicenter phase II study of infusional 5-fluorouracil (5-FU), leucovorin, and oxaliplatin, plus biweekly cetuximab as first-line treatment in patients with metastatic colorectal cancer (CELINE trial)

J. Sakamoto | K. Oba | Kenji Kobayashi | Keishi Nakamura | G. Nishimura | T. Aoyama | Y. Munemoto | M. Kotake | C. Tanaka | N. Nagata | K. Kondo | M. Kataoka | A. Takehara | K. Doden | H. Fujita